Showing results (441-450 of 476) with videos related to
Sort By:
Pageof 48
Trials|May 31, 2020
Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS studyChristine M Bond, Richard Holland, David P Alldred, et al.Emerging Infectious Diseases|April 30, 2025
Detection of SARS-CoV-2 Reinfections Using Nucleocapsid Antibody BoostingEduard Grebe, Daniel Chacreton, Mars Stone, et al.Journal of Public Health (Oxford, England)|March 30, 2025
Effectiveness of a theory-informed intervention to increase care home staff influenza vaccination rates: a cluster randomised controlled trialDavid Wright, Jeanette Blacklock, Veronica Bion, et al.International Journal of Stroke : Official Journal of the International Stroke Society|May 26, 2011
Reading difficulty after stroke: ocular and non ocular causesFiona Rowe, David Wright, Darren Brand, et al.Emerging Infectious Diseases|July 9, 2024
Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood DonorsEduard Grebe, Mars Stone, Bryan R Spencer, et al.Transfusion|October 7, 2024
Spike and nucleocapsid antibody dynamics following SARS-CoV-2 infection and vaccination: Implications for sourcing COVID-19 convalescent plasma from routinely collected blood donationsClara Di Germanio, Xutao Deng, Brendan G Balasko, et al.Hemasphere|June 19, 2026
Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphomaDavid Belada, Faithlore P Gardner, Ana C de Oliveira, et al.Trials|January 23, 2020
Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS studyChristine M Bond, Richard Holland, David P Alldred, et al.BMC Health Services Research|August 20, 2025
Process evaluation of the flucare cluster randomised controlled trial: assessing the implementation of a behaviour change intervention to increase influenza vaccination uptake among care home staff in EnglandThando Katangwe-Chigamba, Faisal Alsaif, Adaku Anyiam-Osigwe, et al.Investigational New Drugs|May 21, 2017
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase CKhaldoun Almhanna, David Wright, Teresa Macarulla Mercade, et al.Pageof 48